A community pharmacy-based cardiovascular risk screening service implemented in Iran
Abstract Background: Cardiovascular disease is a major health concern around the world. Objective: To assess the outcomes and feasibility of a pharmacy-based cardiovascular screening in an urban referral community pharmacy in Iran. Methods: A cross sectional study was conducted in a referral community pharmacy. Subjects aged between 30-75 years without previous diagnose of cardiovascular disease or diabetes were screened. Measurement of all major cardiovascular risk factors, exercise habits, medical conditions, medications, and family history were investigated. Framingham risk score was calculated and high risk individuals were given a clinical summary sheet signed by a clinical pharmacist and were encouraged to follow up with their physician. Subjects were contacted one month after the recruitment period and their adherence to the follow up recommendation was recorded. Results: Data from 287 participants were analyzed and 146 were referred due to at least one abnormal laboratory test. The results showed 26 patients with cardiovascular disease risk greater than 20%, 32 high systolic blood pressure, 22 high diastolic blood pressures, 50 high total cholesterol levels, 108 low HDL-C levels, and 22 abnormal blood glucose levels. Approximately half of the individuals who received a follow up recommendation had made an appointment with their physician. Overall, 15.9% of the individuals received medications and 15.9% received appropriate advice for risk factor modification. Moreover, 7.5% were under evaluation by a physician. Conclusion: A screening program in a community pharmacy has the potential to identify patients with elevated cardiovascular risk factor. A plan for increased patient adherence to follow up recommendations is required.
Main Authors: | , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Centro de Investigaciones y Publicaciones Farmacéuticas
2017
|
Online Access: | http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2017000200006 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1885-642X2017000200006 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1885-642X20170002000062021-03-29A community pharmacy-based cardiovascular risk screening service implemented in IranJahangard-Rafsanjani,ZahraHakimzadeh,NegarSarayani,AmirNajafi,SheydaHeidari,KazemJavadi,Mohammad R.Hadjibabaie,MoloukGholami,Kheirollah Mass Screening Community Pharmacy Services Pharmacies Cardiovascular Diseases Diagnostic Techniques Cardiovascular Iran Abstract Background: Cardiovascular disease is a major health concern around the world. Objective: To assess the outcomes and feasibility of a pharmacy-based cardiovascular screening in an urban referral community pharmacy in Iran. Methods: A cross sectional study was conducted in a referral community pharmacy. Subjects aged between 30-75 years without previous diagnose of cardiovascular disease or diabetes were screened. Measurement of all major cardiovascular risk factors, exercise habits, medical conditions, medications, and family history were investigated. Framingham risk score was calculated and high risk individuals were given a clinical summary sheet signed by a clinical pharmacist and were encouraged to follow up with their physician. Subjects were contacted one month after the recruitment period and their adherence to the follow up recommendation was recorded. Results: Data from 287 participants were analyzed and 146 were referred due to at least one abnormal laboratory test. The results showed 26 patients with cardiovascular disease risk greater than 20%, 32 high systolic blood pressure, 22 high diastolic blood pressures, 50 high total cholesterol levels, 108 low HDL-C levels, and 22 abnormal blood glucose levels. Approximately half of the individuals who received a follow up recommendation had made an appointment with their physician. Overall, 15.9% of the individuals received medications and 15.9% received appropriate advice for risk factor modification. Moreover, 7.5% were under evaluation by a physician. Conclusion: A screening program in a community pharmacy has the potential to identify patients with elevated cardiovascular risk factor. A plan for increased patient adherence to follow up recommendations is required.Centro de Investigaciones y Publicaciones FarmacéuticasPharmacy Practice (Granada) v.15 n.2 20172017-06-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2017000200006en |
institution |
SCIELO |
collection |
OJS |
country |
España |
countrycode |
ES |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-es |
tag |
revista |
region |
Europa del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Jahangard-Rafsanjani,Zahra Hakimzadeh,Negar Sarayani,Amir Najafi,Sheyda Heidari,Kazem Javadi,Mohammad R. Hadjibabaie,Molouk Gholami,Kheirollah |
spellingShingle |
Jahangard-Rafsanjani,Zahra Hakimzadeh,Negar Sarayani,Amir Najafi,Sheyda Heidari,Kazem Javadi,Mohammad R. Hadjibabaie,Molouk Gholami,Kheirollah A community pharmacy-based cardiovascular risk screening service implemented in Iran |
author_facet |
Jahangard-Rafsanjani,Zahra Hakimzadeh,Negar Sarayani,Amir Najafi,Sheyda Heidari,Kazem Javadi,Mohammad R. Hadjibabaie,Molouk Gholami,Kheirollah |
author_sort |
Jahangard-Rafsanjani,Zahra |
title |
A community pharmacy-based cardiovascular risk screening service implemented in Iran |
title_short |
A community pharmacy-based cardiovascular risk screening service implemented in Iran |
title_full |
A community pharmacy-based cardiovascular risk screening service implemented in Iran |
title_fullStr |
A community pharmacy-based cardiovascular risk screening service implemented in Iran |
title_full_unstemmed |
A community pharmacy-based cardiovascular risk screening service implemented in Iran |
title_sort |
community pharmacy-based cardiovascular risk screening service implemented in iran |
description |
Abstract Background: Cardiovascular disease is a major health concern around the world. Objective: To assess the outcomes and feasibility of a pharmacy-based cardiovascular screening in an urban referral community pharmacy in Iran. Methods: A cross sectional study was conducted in a referral community pharmacy. Subjects aged between 30-75 years without previous diagnose of cardiovascular disease or diabetes were screened. Measurement of all major cardiovascular risk factors, exercise habits, medical conditions, medications, and family history were investigated. Framingham risk score was calculated and high risk individuals were given a clinical summary sheet signed by a clinical pharmacist and were encouraged to follow up with their physician. Subjects were contacted one month after the recruitment period and their adherence to the follow up recommendation was recorded. Results: Data from 287 participants were analyzed and 146 were referred due to at least one abnormal laboratory test. The results showed 26 patients with cardiovascular disease risk greater than 20%, 32 high systolic blood pressure, 22 high diastolic blood pressures, 50 high total cholesterol levels, 108 low HDL-C levels, and 22 abnormal blood glucose levels. Approximately half of the individuals who received a follow up recommendation had made an appointment with their physician. Overall, 15.9% of the individuals received medications and 15.9% received appropriate advice for risk factor modification. Moreover, 7.5% were under evaluation by a physician. Conclusion: A screening program in a community pharmacy has the potential to identify patients with elevated cardiovascular risk factor. A plan for increased patient adherence to follow up recommendations is required. |
publisher |
Centro de Investigaciones y Publicaciones Farmacéuticas |
publishDate |
2017 |
url |
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2017000200006 |
work_keys_str_mv |
AT jahangardrafsanjanizahra acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT hakimzadehnegar acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT sarayaniamir acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT najafisheyda acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT heidarikazem acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT javadimohammadr acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT hadjibabaiemolouk acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT gholamikheirollah acommunitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT jahangardrafsanjanizahra communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT hakimzadehnegar communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT sarayaniamir communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT najafisheyda communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT heidarikazem communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT javadimohammadr communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT hadjibabaiemolouk communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran AT gholamikheirollah communitypharmacybasedcardiovascularriskscreeningserviceimplementediniran |
_version_ |
1755999639564189696 |